350 related articles for article (PubMed ID: 25972390)
1. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.
Morgan C; McBeth J; Cordingley L; Watson K; Hyrich KL; Symmons DP; Bruce IN
Rheumatology (Oxford); 2015 Oct; 54(10):1780-91. PubMed ID: 25972390
[TBL] [Abstract][Full Text] [Related]
2. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients.
Wabe N; Lee A; Wechalekar M; McWilliams L; Proudman S; Wiese M
Int J Clin Pract; 2019 Jul; 73(7):e13375. PubMed ID: 31120169
[TBL] [Abstract][Full Text] [Related]
4. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study.
Balsa A; García de Yébenes MJ; Carmona L;
Ann Rheum Dis; 2022 Mar; 81(3):327-334. PubMed ID: 34844924
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Jørgensen TS; Kristensen LE; Christensen R; Bliddal H; Lorenzen T; Hansen MS; Østergaard M; Jensen J; Zanjani L; Laursen T; Butt S; Dam MY; Lindegaard HM; Espesen J; Hendricks O; Kumar P; Kincses A; Larsen LH; Andersen M; Næser EK; Jensen DV; Grydehøj J; Unger B; Dufour N; Sørensen V; Vildhøj S; Hansen IM; Raun J; Krogh NS; Hetland ML
Rheumatology (Oxford); 2015 Dec; 54(12):2156-65. PubMed ID: 26175471
[TBL] [Abstract][Full Text] [Related]
6. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy.
Raghunath S; Hijjawi R; Hoon E; Shanahan EM; Goldblatt F
Clin Rheumatol; 2019 Oct; 38(10):2699-2707. PubMed ID: 31172365
[TBL] [Abstract][Full Text] [Related]
7. Pilot study assessing the novel use of musculoskeletal ultrasound in patients with rheumatoid arthritis to improve patient attitudes and adherence to medication.
Joplin SK; van der Zwan R; Bagga H; Joshua F; Wong PK
Int J Rheum Dis; 2016 Jul; 19(7):658-64. PubMed ID: 24839920
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis.
Ko KM; Moon SJ; Koh JH; Pae CU; Min JK
Yonsei Med J; 2020 May; 61(5):406-415. PubMed ID: 32390364
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J
Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236
[TBL] [Abstract][Full Text] [Related]
10. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
[TBL] [Abstract][Full Text] [Related]
11. Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine. A prospective cohort study.
de Thurah A; Nørgaard M; Harder I; Stengaard-Pedersen K
Rheumatol Int; 2010 Sep; 30(11):1441-8. PubMed ID: 19823840
[TBL] [Abstract][Full Text] [Related]
12. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register.
Matcham F; Davies R; Hotopf M; Hyrich KL; Norton S; Steer S; Galloway J
Rheumatology (Oxford); 2018 May; 57(5):835-843. PubMed ID: 29447376
[TBL] [Abstract][Full Text] [Related]
13. Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
Bluett J; Morgan C; Thurston L; Plant D; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; Cordingley L; Barton A;
Rheumatology (Oxford); 2015 Mar; 54(3):494-9. PubMed ID: 25213131
[TBL] [Abstract][Full Text] [Related]
14. Why Do Patients with Chronic Inflammatory Rheumatic Diseases Discontinue Their Biologics? An Assessment of Patients' Adherence Using a Self-report Questionnaire.
Betegnie AL; Gauchet A; Lehmann A; Grange L; Roustit M; Baudrant M; Bedouch P; Allenet B
J Rheumatol; 2016 Apr; 43(4):724-30. PubMed ID: 26879361
[TBL] [Abstract][Full Text] [Related]
15. Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception.
Suh YS; Cheon YH; Kim HO; Kim RB; Park KS; Kim SH; Lee SG; Park EK; Hur J; Lee SI
Korean J Intern Med; 2018 Jan; 33(1):203-210. PubMed ID: 28859470
[TBL] [Abstract][Full Text] [Related]
16. The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
Cea-Calvo L; Raya E; Marras C; Salman-Monte TC; Ortiz A; Salvador G; Monteagudo I; Carmona L; Fernandez S; Arteaga MJ; Calvo-Allén J
Rheumatol Int; 2018 Sep; 38(9):1735-1740. PubMed ID: 29959469
[TBL] [Abstract][Full Text] [Related]
17. Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern Sweden.
Söderlin MK; Jacobsson LT; Petersson IF; Englund M; Saxne T; Geborek P
J Rheumatol; 2009 Jun; 36(6):1166-9. PubMed ID: 19411397
[TBL] [Abstract][Full Text] [Related]
18. Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.
Salgado E; Maneiro Fernández JR; Souto Vilas A; Gómez-Reino JJ
Rheumatol Int; 2018 Mar; 38(3):467-472. PubMed ID: 29356882
[TBL] [Abstract][Full Text] [Related]
19. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
20. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
